Evercore Wealth Management, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 200 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
Evercore Wealth Management, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$260,000
+26.8%
3,4090.0%0.01%
+66.7%
Q4 2021$205,000
-1.0%
3,4090.0%0.00%
-25.0%
Q2 2021$207,000
-13.4%
3,4090.0%0.00%
-20.0%
Q1 2021$239,000
+17.2%
3,4090.0%0.01%
+25.0%
Q4 2020$204,000
-0.5%
3,4090.0%0.00%
-20.0%
Q3 2020$205,000
+31.4%
3,4090.0%0.01%
-16.7%
Q4 2017$156,000
+21.9%
3,4090.0%0.01%
+20.0%
Q3 2017$128,000
-21.5%
3,4090.0%0.01%
-16.7%
Q2 2017$163,000
+5.2%
3,4090.0%0.01%0.0%
Q1 2017$155,000
+40.9%
3,4090.0%0.01%
+20.0%
Q4 2016$110,000
-6.0%
3,4090.0%0.01%0.0%
Q3 2016$117,000
+1.7%
3,4090.0%0.01%0.0%
Q2 2016$115,000
-36.5%
3,4090.0%0.01%
-37.5%
Q1 2016$181,000
-30.9%
3,4090.0%0.01%
-33.3%
Q4 2015$262,000
+44.8%
3,409
-22.7%
0.01%
+33.3%
Q3 2015$181,000
-42.0%
4,4090.0%0.01%
-35.7%
Q2 2015$312,000
-35.1%
4,409
-18.5%
0.01%
-36.4%
Q1 2015$481,000
-6.6%
5,409
-6.9%
0.02%
-15.4%
Q4 2014$515,000
-19.7%
5,809
-12.1%
0.03%
-18.8%
Q3 2014$641,000
-44.6%
6,609
-47.5%
0.03%
-46.7%
Q2 2014$1,156,000
+17.2%
12,582
-10.7%
0.06%
+9.1%
Q1 2014$986,000
+163.6%
14,082
+116.6%
0.06%
+161.9%
Q4 2013$374,000
+55.8%
6,500
+30.0%
0.02%
+50.0%
Q3 2013$240,000
+65.5%
5,0000.0%0.01%
+75.0%
Q2 2013$145,0005,0000.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Tamarack Advisers, LP 360,000$21,845,0006.19%
Gagnon Advisors, LLC 213,217$12,938,0004.92%
GAGNON SECURITIES LLC 499,333$30,300,0004.30%
Spyglass Capital Management LLC 2,117,673$128,500,0002.86%
NEUMEIER POMA INVESTMENT COUNSEL LLC 646,530$39,231,0002.30%
Paulson & Co. 1,273,161$77,255,0001.85%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 212,112$12,871,0001.44%
Tygh Capital Management, Inc. 152,332$9,244,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,147,000$69,600,0001.24%
Rock Springs Capital Management LP 1,025,000$62,197,0001.23%
View complete list of PACIRA PHARMACEUTICALS INC shareholders